Congenital Hematological Disorder Completed Phase 1 Trials for Vatreptacog alfa (DB12409)
Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0081791 (Congenital Hematological Disorder) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00822185 | Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers | Treatment |